AR19, a manipulation-resistant formulation of amphetamine sulfate, was created to address the problem of non-oral use of stimulant medications (eg, smoking, injecting). In this video, Dr Faraone highlights the findings and implications of a recent randomized controlled trial of AR19 in adult ADHD.
Insights August 24, 2021
AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adult ADHD
Vol 86 • 2025 • Number 2
Read the Current Issue
Original Research
Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum
Original Research
Valbenazine in Elderly Adults With Tardive Dyskinesia
Academic Highlights
Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report
Original Research
Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study
Consensus Statement
Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations
Brief Report